NAGE compared with MFIN: revenue, margins and what each company keeps, and the suppliers and customers both name

NAGENiagen Bioscience, Inc.

Mkt capRevenueRevenue

MFINMedallion Financial Corp

Mkt capRevenueRevenue

Compare

NAGENiagen Bioscience, Inc.

MFINMedallion Financial Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

NAGENiagen Bioscience, Inc.

2.07▼−1.90%· post 2.07

Mkt cap$163.9MRevenue$27MQ3 FY26Revenue$129MFY25

MFINMedallion Financial Corp

10.05▲+1.31%· post 10.01

ClosedNov 6 '26

Mkt cap$224.1MRevenue$62MQ3 FY26Revenue$248MFY25

Compare

ClosedNov 6 '26

NAGENiagen Bioscience, Inc.

MFINMedallion Financial Corp

2.07▼−1.90%post 2.07

Price

10.05▲+1.31%post 10.01

$163.9M

Mkt cap

$224.1M

Q3 FY26$27M

Revenue

$62MQ3 FY26

FY25$129M

Revenue

$248MFY25

NAGE2.07▼−1.90%vsMFIN10.05▲+1.31%ClosedNov 6 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NAGE 5

—A.S. Watsonunlistedcustomer

AMZNAmazoncustomer

—W.R. Grace & Co.-Connunlistedsupplier

—Queen's University Belfastunlistedsupplier

1 more · NAGE chain ›

Shared 0

No disclosed counterparties: MFIN.

Only MFIN 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR